First Bank & Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.99M | Sell |
11,014
-2,013
| -15% | -$689K | 0.59% | 33 |
|
|
2026
Q1 | $4.58M | Buy |
13,027
+98
| +0.8% | +$34.9K | 0.74% | 29 |
|
|
2025
Q4 | $4.23M | Buy |
12,929
+512
| +4% | +$162K | 0.69% | 30 |
|
|
2025
Q3 | $3.5M | Buy |
12,417
+1,155
| +10% | +$335K | 0.59% | 43 |
|
|
2025
Q2 | $3.14M | Buy |
11,262
+732
| +7% | +$207K | 0.56% | 46 |
|
|
2025
Q1 | $3.28M | Buy |
10,530
+871
| +9% | +$257K | 0.64% | 41 |
|
|
2024
Q4 | $2.52M | Sell |
9,659
-1,030
| -10% | -$306K | 0.48% | 50 |
|
|
2024
Q3 | $3.44M | Sell |
10,689
-271
| -2% | -$88.6K | 0.65% | 34 |
|
|
2024
Q2 | $3.42M | Buy |
10,960
+997
| +10% | +$293K | 0.7% | 30 |
|
|
2024
Q1 | $2.83M | Sell |
9,963
-1,932
| -16% | -$565K | 0.59% | 37 |
|
|
2023
Q4 | $3.43M | Sell |
11,895
-1,438
| -11% | -$392K | 0.83% | 25 |
|
|
2023
Q3 | $3.58M | Buy |
13,333
+2,273
| +21% | +$567K | 0.94% | 18 |
|
|
2023
Q2 | $2.46M | Buy |
11,060
+4,620
| +72% | +$1.07M | 0.62% | 36 |
|
|
2023
Q1 | $1.56M | Sell |
6,440
-3,166
| -33% | -$777K | 0.41% | 64 |
|
|
2022
Q4 | $2.52M | Buy |
9,606
+962
| +11% | +$258K | 0.7% | 27 |
|
|
2022
Q3 | $1.95M | Buy |
8,644
+1,076
| +14% | +$261K | 0.72% | 32 |
|
|
2022
Q2 | $1.84M | Buy |
7,568
+453
| +6% | +$111K | 0.6% | 41 |
|
|
2022
Q1 | $1.72M | Buy |
7,115
+293
| +4% | +$67.3K | 0.53% | 44 |
|
|
2021
Q4 | $1.53M | Buy |
6,822
+4,314
| +172% | +$910K | 0.65% | 43 |
|
|
2021
Q3 | $533K | Buy |
2,508
+209
| +9% | +$48.1K | 0.24% | 94 |
|
|
2021
Q2 | $560K | Buy |
2,299
+108
| +5% | +$26.6K | 0.27% | 88 |
|
|
2021
Q1 | $545K | Sell |
2,191
-12
| -0.5% | -$2.86K | 0.27% | 88 |
|
|
2020
Q4 | $507K | Buy |
2,203
+264
| +14% | +$60.9K | 0.32% | 84 |
|
|
2020
Q3 | $492K | Buy |
1,939
+5
| +0.3% | +$1.24K | 0.33% | 78 |
|
|
2020
Q2 | $456K | Buy |
1,934
+1,229
| +174% | +$280K | 0.34% | 77 |
|
|
2020
Q1 | $143K | Sell |
705
-2,010
| -74% | -$439K | 0.13% | 135 |
|
|
2019
Q4 | $655K | Buy |
2,715
+2,675
| +6,688% | +$590K | 0.48% | 70 |
|
|
2019
Q3 | $8K | Sell |
40
-7
| -15% | -$1.34K | 0.01% | 317 |
|
|
2019
Q2 | $9K | Buy |
47
+7
| +18% | +$1.25K | 0.01% | 290 |
|
|
2019
Q1 | $8K | Buy |
+40
| New | +$7.64K | 0.01% | 248 |
|
Other funds holding AMGN
First Bank & Trust's AMGN Position: Q2 2026 in Review
First Bank & Trust reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $689K and leaving 11,014 shares worth $3.99M. The position accounts for 0.59% of the portfolio, ranked #33.
First Bank & Trust first reported a position in AMGN in Q1 2019 and has held it in 30 quarters since. The position peaked at $4.58M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- First Bank & Trust held 11,014 shares of Amgen worth $3.99M as of Q2 2026.
- First Bank & Trust sold 2,013 Amgen shares in Q2 2026, an estimated $689K.
- Amgen made up 0.59% of First Bank & Trust's portfolio in Q2 2026, its #33 holding.
- First Bank & Trust first reported a position in Amgen in Q1 2019 and has held it in 30 quarters since.
- First Bank & Trust's Amgen position peaked at $4.58M in Q1 2026.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.